Press Releases

ROCK HILL, S.C., Nov. 19, 2019 /PRNewswire/ -- At Formnext 2019,

LUND, Sweden, Nov. 19, 2019 /PRNewswire/ -- Hansa Biopharma today announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on May 22, 2019 and has the following composition:

OSLO, Norway, Nov. 19, 2019 /PRNewswire/ -- The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 19th November 2019 resolved to grant Dr Gabriele Elbl, Vice President Global Regulatory Affairs, 30,000 Performance Share Units ("PSUs") in connection with her appointment an

DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise to the visitors, at the high impact healthcare trade shows, MEDICA, in

OSLO, Norway, Nov. 19, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces its results for the third quarter 2019. A presentation by the company's senior management team will take place today in Oslo at 08:30 CET, see details below. Eduardo Bravo, CEO

 FDA granted Fast Track Designation for 2L Acute Myeloid Leukaemia (AML)High Impact oral presentation of 2L NSCLC clinical data at SITCMet primary and secondary endpoints in non-small cell lung cancer (NSCLC) Phase II clinical trial in patients previously treated with chemotherapy (cohort A)Proprietary composite AXL

Khiron Life Sciences establishes early mover position to build its brand and product offering in the United Kingdom's nascent medical cannabis market Project Twenty21 will study medical cannabis's therapeutic effects on 20,000 patients - and build largest ever evidence base for UK National Health Service (NHS) provision of these medicines Real-world data registry wi

NEW YORK, Nov. 18, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. ("Zynerba" or the "Company") (NASDAQ:  ZYNE) and certain of its officers.  The class action, filed in United States District Court, Eastern District of Pe

NEW YORK, Nov. 18, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ: ABEO) and certain of its officers.  The class action, filed in United States District Court, for the Southern District of

NEW YORK, Nov. 18, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Myriad Genetics, Inc. ("Myriad" or the "Company") (NASDAQ: MYGN) and certain of its officers.  The class action, filed in United States District Court, for the District of Utah,